Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
93
Views
13
CrossRef citations to date
0
Altmetric
Original Research

LncRNA FENDRR Inhibits Gastric Cancer Cell Proliferation and Invasion via the miR-421/SIRT3/Notch-1 Axis

Jia Ma1 Department of Surgical Oncology, Shaanxi Provincial People’s Hospital, Xi’an, 710068, Shaanxi, People’s Republic of China
,
Gang Zhao2 Department of Surgical Oncology, Pucheng County Hospital, Weinan, 715500, Shaanxi, People’s Republic of China
,
Jia Du1 Department of Surgical Oncology, Shaanxi Provincial People’s Hospital, Xi’an, 710068, Shaanxi, People’s Republic of China
,
Jiang Li1 Department of Surgical Oncology, Shaanxi Provincial People’s Hospital, Xi’an, 710068, Shaanxi, People’s Republic of China
,
Guangshuai Lin1 Department of Surgical Oncology, Shaanxi Provincial People’s Hospital, Xi’an, 710068, Shaanxi, People’s Republic of China
&
Jianfei Zhang1 Department of Surgical Oncology, Shaanxi Provincial People’s Hospital, Xi’an, 710068, Shaanxi, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1449-2523
ORCID Icon
Pages 9175-9187 | Published online: 14 Dec 2021

References

  • Cao Q, Liu F, Ji K, et al. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. J Exp Clin Cancer Res. 2017;36(1):29. doi:10.1186/s13046-017-0499-z28193228
  • Hao NB, He Y-F, Li X-Q, Wang K, Wang R-L. The role of miRNA and lncRNA in gastric cancer. Oncotarget. 2017;8(46):81572–81582. doi:10.18632/oncotarget.1919729113415
  • Zhao L, Kong H, Sun H, Chen Z, Chen B, Zhou M. LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448. J Cell Physiol. 2018;233(5):4044–4055.28657147
  • Luo T, Zhao J, Lu Z, et al. Characterization of long non-coding RNAs and MEF2C-AS1 identified as a novel biomarker in diffuse gastric cancer. Transl Oncol. 2018;11(5):1080–1089. doi:10.1016/j.tranon.2018.06.00730005210
  • Xu TP, Huang MD, Xia R, et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol. 2014;7:63. doi:10.1186/s13045-014-0063-725167886
  • Liu H, Zhang Z, Han Y, et al. The FENDRR/FOXC2 axis contributes to multidrug resistance in gastric cancer and correlates with poor prognosis. Front Oncol. 2021;11:634579. doi:10.3389/fonc.2021.63457933869020
  • Chen J, Wu L, Sun Y, et al. Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer. PeerJ. 2019;7:e7002. doi:10.7717/peerj.700231245174
  • Ge X, Liu X, Lin F, et al. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer. Oncotarget. 2016;7(17):24466–24482. doi:10.18632/oncotarget.822827016414
  • Yang P, Zhang M, Liu X, Pu H. MicroRNA-421 promotes the proliferation and metastasis of gastric cancer cells by targeting claudin-11. Exp Ther Med. 2017;14(3):2625–2632. doi:10.3892/etm.2017.479828962204
  • Huang KH, Hsu CC, Fang WL, et al. SIRT3 expression as a biomarker for better prognosis in gastric cancer. World J Surg. 2014;38(4):910–917. doi:10.1007/s00268-013-2359-024322174
  • Wang L, Wang WY, Cao LP. SIRT3 inhibits cell proliferation in human gastric cancer through down-regulation of Notch-1. Int J Clin Exp Med. 2015;8(4):5263–5271.26131100
  • Yan L, Wenwen Z, Pengying L, et al. Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer. Onco Targets Ther. 2018;11:1403–1412.29559798
  • Gong F, Dong D, Zhang T, Xu W. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR. Eur J Pharmacol. 2019;853:345–352.30981768
  • Zhao YY, Mao MW, Zhang WJ, et al. Expanding RNA binding specificity and affinity of engineered PUF domains. Nucleic Acids Res. 2018;46(9):4771–4782. doi:10.1093/nar/gky13429490074
  • Wang JX, Yi Y, Li YW, et al. Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection. BMC Cancer. 2014;14(1):297. doi:10.1186/1471-2407-14-29724774224
  • Li S, Banck M, Mujtaba S, Zhou MM, Sugrue MM, Walsh MJ. p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PloS one. 2010;5(5):e10486.
  • Kim HS, Jacobs PK. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010;17(1):41–52. doi:10.1016/j.ccr.2009.11.02320129246
  • Xiao K, Jiang J, Wang W. Sirt3 is a tumor suppressor in lung adenocarcinoma cells. Oncol Rep. 2013;30(3):1323–1328. doi:10.3892/or.2013.260423842789
  • Hong K-J, Wu D-C, Cheng K-H, Chen L-T, Hung W-C. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation. J Cell Physiol. 2014;229(2):191–201. doi:10.1002/jcp.2443423881612
  • Han B, Liu SH, Guo WD, et al. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells. World journal of gastroenterology. 2015;21(33):9727–9735.
  • Feng Y-Z, Shiozawa T, Miyamoto T, et al. Overexpression of Hedgehog signaling molecules and its involvement in the proliferation of endometrial carcinoma cells. Clin Cancer Res. 2007;13(5):1389–1398. doi:10.1158/1078-0432.CCR-06-140717332280

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.